John A. Latham, Chief Scientific Officer at ALDER BIOPHARMACEUTICALS INC (ALDR), sold 25,002 shares at $13.40 ($336K) on 2018-11-01, disclosed to the SEC on 2018-11-05.
Scheduled sale ($336k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.40 | 23,683 | $317K | 94.6% |
| 2 | $13.78 | 1,319 | $18K | 5.4% |
| Total | $13.42 avg | 25,002 | $336K | 100% |
| Filing → |
| ALDR | SELL | 2018-08-02 | $489K | — | Filing → |
| ALDR | SELL | 2018-07-03 | $387K | — | Filing → |
| ALDR | SELL | 2018-06-05 | $446K | — | Filing → |